gnrh agonist triptorelin gonapeptyl daily (Ferring Pharmaceuticals)
90
Structured Review
Ferring Pharmaceuticals
gnrh agonist triptorelin gonapeptyl daily
Gnrh Agonist Triptorelin Gonapeptyl Daily, supplied by Ferring Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/triptorelin+gonapeptyl/triptorelin+decapeptyl/pm40050021-64-16-22
Average 90 stars, based on 1 article reviews
Gnrh Agonist Triptorelin Gonapeptyl Daily, supplied by Ferring Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/triptorelin+gonapeptyl/triptorelin+decapeptyl/pm40050021-64-16-22
Average 90 stars, based on 1 article reviews
gnrh agonist triptorelin gonapeptyl daily - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Predicting suboptimal oocyte yield following GnRH agonist trigger by measuring serum LH at the start of ovarian stimulation. Article Snippet: When at least three follicles of 17 mm or more were visible, triggering of final oocyte maturation was carried out with a single subcutaneous dose of GnRH agonist, 0.2 mg of Article Title: Progestin primed ovarian stimulation using dydrogesterone from day 7 of the cycle onwards in oocyte donation cycles: a longitudinal study. Article Snippet: Research question: Does a progestin-primed ovarian stimulation (PPOS) protocol with dydrogesterone from cycle day 7 yield similar outcomes compared with a gonadotrophin-releasing hormone (GnRH) antagonist protocol in the same oocyte donors?. Design: This retrospective longitudinal study included 128 cycles from 64 oocyte donors.. All oocyte donors had the same type of gonadotrophin and daily dose in both stimulation cycles. Article Title: Elevated estradiol levels on hCG trigger day adversely effects on the clinical pregnancy rates of blastocyst embryo transfer but not cleavage-stage embryo transfer in fresh cycles: a retrospective cohort study Article Snippet: Patients received one dose of 1.0 mg Injection:Article Title: Combining fertility preservation procedures to spread the eggs across different baskets: a feasibility study. Article Snippet: procedures to spread the eggs across different baskets: a feasibility study S. Delattre, I. Segers, E. Van Moer, P. Drakopoulos, I. Mateizel, L. Enghels, H. Tournaye, and M. De Vos* Centre for Reproductive Medicine, UZ Brussel, Brussels, Belgium Follicle Biology Laboratory (FOBI), UZ Brussel, Vrije Universiteit Brussel, Brussels, Belgium Department of Obstetrics, Gynecology, Perinatology and Reproductology, Institute of Professional Education, Sechenov University, Moscow, Russia Article Title: Reproductive outcomes in women opting for fertility preservation after fertility-sparing surgery for borderline ovarian tumors. Article Snippet: Purpose What are the reproductive outcomes of women who had fertility preservation (FP) using either oocyte or embryo vitrification after fertility-sparing surgery (FSS) for a borderline ovarian tumor (BOT)?. Methods A retrospective, single-center cohort study was conducted between January 2013 and December 2021.. Patients with BOT who resorted to FP by vitrifying oocytes or embryos were included. Article Title: GnRH agonist supplementation in hormone replacement therapy-frozen embryo transfer cycles: a randomized controlled trial. Article Snippet: Research question: Will two boluses of gonadotrophin-releasing hormone agonist (GnRHa) during hormone replacement therapy–frozen embryo transfer (HRT–FET) cycles reduce the total pregnancy loss rate?. Design: Randomized controlled trial including a total of 287 HRT–FET cycles performed between 2013 and 2019.. After randomization participants allocated to the GnRHa group (n = 144) underwent a standard HRT protocol, supplemented with a total of two boluses of triptorelin 0.1 mg; one bolus 2 days before starting vaginal progesterone and one bolus on the 7th day of progesterone. Article Title: Effect of paternal age on assisted reproductive outcomes in ICSI donor cycles. Article Snippet: 1Department of Embryology, British Cyprus IVFHospital, Nicosia, Cyprus 2Department of Histology and Embryology, Faculty ofMedicine, Cyprus International University, Nicosia, Cyprus 3Department of Zoology, Faculty of Chemical and Life Sciences, AbdulWali Khan University, Mardan, Pakistan 4Department of Basic Sciences and Humanities, Faculty of Arts and Sciences, Cyprus International University, Nicosia, Cyprus 5Department of Obstetrics &Gynecology, British Cyprus IVFHospital, Nicosia, Cyprus |